It appears glaxo is working on a drug that can treat COPD and depression in the company documents the drug is Iosmapimod (856553) a p38 kinase inhibitor which is indicated for cardiovascular disease (also COPD & depression).This is promising news for those friends and families afflicted by the diesease....The drug is said to be in phase 2 clinical trials which means there is atleast another 4 year or so until it is on the pharmacy shelf.
1 comment:
Post a Comment